TRT 'good results' claims: what the evidence actually supports

What did @chris_practical actually say?

The creator made a specific argument: DHT derivatives produce a distinct psychological and physical effect, described as feeling "very masculine and ambitious," but come with real costs, specifically hairline recession and worse lipid profiles compared to testosterone alone. He also noted these compounds are nearly impossible to obtain through legitimate TRT clinics, with anavar being a partial exception he immediately dismissed. He then positioned himself as someone who uses these with clients regularly and invited people to DM him for guidance.

That last part is where things get complicated. The clinical observations about DHT derivatives are worth taking seriously. The sales pitch at the end is not a medical service, it's a coaching arrangement, and the distinction matters legally and practically for anyone considering this path.

Does the science back this up?

On the core pharmacology, yes, largely. DHT-derived anabolic steroids, including compounds like stanozolol, masteron (drostanolone), and primobolan (methenolone), do not aromatize to estrogen, which changes the hormonal environment meaningfully. The subjective reports of increased drive and well-being are consistent with what androgen receptor binding patterns would predict, though the evidence here is mostly observational rather than from controlled trials.

The lipid claim is well-supported. DHT derivatives, particularly oral forms, are associated with significant reductions in HDL cholesterol. Hartgens and Kuipers (2004, Sports Medicine) documented that anabolic-androgenic steroids can reduce HDL by 20-70% depending on compound and dose. Oral 17-alpha alkylated compounds hit harder than injectables. The hairline claim is also pharmacologically sound: DHT is the primary driver of androgenic alopecia, and compounds that resist conversion away from DHT, or directly bind androgen receptors in hair follicles, accelerate this process in genetically susceptible individuals (Randall, 2008, Journal of Endocrinology).

What did they get right, and what did they get wrong?

Credit where it is due: the creator did not oversell this. Saying "it's not all rainbows and sunshine" before naming specific risks is more honest than most TikTok content in this category. The framing that these are add-ons rather than replacements, and that access through legitimate clinics is difficult, reflects reality accurately.

What's missing is more significant than what's wrong. There is no mention of cardiovascular risk beyond lipids. DHT derivatives, especially oral ones, carry hepatotoxicity risk for 17-alpha alkylated versions (Dickerman et al., 1995, Chest). There is no discussion of the legal status of most of these compounds in the US, where they are Schedule III controlled substances. And "DM me for safety" is doing a lot of work as a disclaimer for what amounts to advising people on unlicensed drugs. The phrase "cycle safer" in the caption implies harm reduction for illicit use, which is a different conversation than TRT optimization.

What should you actually know?

If you are on testosterone replacement therapy through a licensed provider, adding a DHT derivative is not something most clinics will prescribe, and for reasons that go beyond caution. The risk-benefit math changes significantly when you layer compounds. Lipid deterioration that looks manageable on paper can translate to measurable cardiovascular risk over years, not months.

The subjective "feel" that people describe on DHT derivatives is real in the sense that androgen receptor activity does influence mood, confidence, and drive. But subjective benefit is not a clinical endpoint. Anyone drawn to this approach should at minimum get a full lipid panel, liver enzymes, hematocrit, and blood pressure monitoring if they proceed, and they should do so with a physician who knows what they are taking, not just a DM conversation.

Anavar (oxandrolone) is the one compound in this class with actual clinical trial data, including use in HIV wasting and recovery from burns (Orr and Singh, 2004, Sports Medicine). Even there, lipid effects are real. Nothing in this category is free of trade-offs.